Roivant Sciences Ltd.
- SEC CIK
- 0001635088
In the past year, 1 open-market purchase filing worth $350.0M and no sales.
Current role at each company
- IMVT Immunovant, Inc.Director, 10% Owneras of Dec 12, 2025
- ABUS Arbutus Biopharma Corp10% Owneras of Oct 20, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $350.0M
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$350.0M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Roivant Sciences Ltd. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IMVT Immunovant, Inc.
Director, 10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 (view filing) | Dec 12 | Same day | Roivant Sciences Ltd.Director, 10% Owner | PPurchaseCommon Stock, $0.0001 par value per share | +16.7M | $21.00 | +$350.0M | +17.2%113.3M after | |
| Jan 15, 2025 (view filing) | Jan 13 | 2 days | Roivant Sciences Ltd.Director, 10% Owner | PPurchaseCommon Stock, $0.0001 par value per share | +16.8M | $20.00 | +$336.9M | +21.1%96.7M after | |
| Oct 4, 2023 (view filing) | Oct 2 | 2 days | Roivant Sciences Ltd.Director, 10% Owner | PPurchaseCommon Stock, $0.0001 par value per share | +1.53M | $38.00 | +$58.0M | +1.9%79.8M after | |
| Oct 7, 2022 (view filing) | Oct 6 | 1 day | Roivant Sciences Ltd.10% Owner | PPurchaseCommon Stock, $0.0001 par value per share | +416.7K | $6.00 | +$2.50M | +0.6%73.8M after |